These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 24965746)

  • 1. The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells.
    Liu H; Zhang X; Li J; Sun B; Qian H; Yin Z
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):189-201. PubMed ID: 24965746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological significance of circulating tumor cells in cancer.
    Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
    Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells.
    Kölbl AC; Jeschke U; Andergassen U
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
    Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
    BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
    Chen J; Cao SW; Cai Z; Zheng L; Wang Q
    Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
    Lowes LE; Allan AL
    Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intersecting pathways: The role of hybrid E/M cells and circulating tumor cells in cancer metastasis and drug resistance.
    Hariri A; Mirian M; Khosravi A; Zarepour A; Iravani S; Zarrabi A
    Drug Resist Updat; 2024 Sep; 76():101119. PubMed ID: 39111134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting circulating tumor cells to prevent metastases.
    Gostomczyk K; Marsool MDM; Tayyab H; Pandey A; Borowczak J; Macome F; Chacon J; Dave T; Maniewski M; Szylberg Ł
    Hum Cell; 2024 Jan; 37(1):101-120. PubMed ID: 37874534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer.
    Li S; Chen Q; Li H; Wu Y; Feng J; Yan Y
    Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1.
    Hu B; Tian X; Li Y; Liu Y; Yang T; Han Z; An J; Kong L; Li Y
    Cancer Med; 2020 Apr; 9(8):2686-2697. PubMed ID: 32077634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
    Hamilton G; Rath B
    Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
    Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
    Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme.
    Chistiakov DA; Chekhonin VP
    Exp Mol Pathol; 2018 Oct; 105(2):166-174. PubMed ID: 30028961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial to mesenchymal plasticity: role in cancer progression.
    Raja R; Pandey A; Kumar P
    Front Biosci (Landmark Ed); 2020 Jan; 25(5):838-873. PubMed ID: 31585920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
    Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
    Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMT status of circulating breast cancer cells and impact of fluidic shear stress.
    Jin Y; Cai W; Zhao C; Yang F; Yang C; Zhang X; Zhou Q; Zhao W; Zhang C; Zhang F; Wang M; Li M
    Exp Cell Res; 2022 Dec; 421(1):113385. PubMed ID: 36228736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
    Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
    BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
    Mitra A; Mishra L; Li S
    Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.